InnoSphere is a medical device company, developing brain stimulation treatments for cognitive disorders, focusing on ADHD.
InnoSphere, with its patented technologies, and in collaboration with Yale University and the University of Oxford, is achieving significant clinical results by alleviating ADHD symptoms in clinical trials at Hadassah Medical Center in Jerusalem and at King’s College of London.
The brain stimulation treatment protocols are personalized using the AF-RNS™ technology and a unique AI algorithm designed to optimize the efficacy of the treatment per patient.
The Company’s innovative wearable device for treating ADHD offers hope for long-term improvement in the quality of life of millions of patients. The technology is based on recent collaborative research conducted with leading worldwide institutes and universities in the field of cognitive neuroscience.
InnoSphere is based in Haifa and in Berlin, and its management team and advisory board include successful entrepreneurs, engineers with proven expertise in medical devices, and key opinion-leaders in cognitive neuroscience and pediatric neurology.
Invest in InnoSphere
InnoSphere is raising a Series A round of funding intended for achieving regulatory compliance of its ADHD medical device, and launching sales by 2021. Investors please contact: Rami.Shacour@inno-sphere.com